Invasion of the body snatchers: Prescription privileges, professional schools, and the drive to create a new behavioral health profession

Clinical Psychology: Science and Practice

Volumn 9, Issue 3, 2002, Pages 264-269

  Hayes, Steven C ^a   Chang, Grace ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

Empirically based treatment; Prescription privileges; Professional schools

Indexed keywords

PSYCHOTROPIC AGENT;

AUTHORITY; BEHAVIORAL MEDICINE; CLINICAL PSYCHOLOGY; HEALTH HAZARD; HUMAN; MEDICAL PRACTICE; MEDICAL PROFESSION; MEDICAL SCHOOL; NONMEDICAL OCCUPATIONS; PRESCRIPTION; PSYCHOPHARMACOLOGY; PUBLIC HEALTH; REVIEW;

EID: 0142123782     PISSN: 09695893     EISSN: None     Source Type: Journal    
DOI: 10.1093/clipsy/9.3.264     Document Type: Review

References (34)

1. Antonuccio, D. O., Danton, W. G., DeNelsky, G. Y., Greenberg, R. P., & Gordon, J. S. (1999). Raising questions about antidepressants. Psychotherapy and Psychosomatics, 68, 3-14.
2. Antonuccio, D. O., Thomas, M., & Danton, W. G. (1997). A cost-effectiveness analysis of cognitive behavior therapy and fluoxetine (prozac) in the treatment of depression. Behavior Therapy, 28, 187-210.
3. Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. Journal of the American Medical Association, 283, 2529-2536.
4. Bodenheimer, T. (2000). Uneasy alliance: Clinical investigators and the pharmaceutical industry. New England Journal of Medicine, 342, 1539-1544.
5. Collins, W. J. (2000). Licensed psychologists: Psychopharmacology training. Dissertation Abstracts International: Section B: The Sciences & Engineering, 61(5-B), 2750.
6. Danton, W. G., & Antonuccio, D. O. (1997). A focused empirical analysis of treatments for panic and anxiety. In S. Fisher, R. P. Greenberg, & P. Roger (Eds.), From placebo to panacea: Putting psychiatric drugs to the test (pp. 229-280). New York: Wiley.
7. DeLeon, P. H. (1993, September). Untitled. Los Angeles Times, Sept. 7, p. E6.
8. DeLeon, P. H., Fox, R. E., & Graham, S. R. (1991). Prescription privileges: Psychology's next frontier? American Psychologist, 46, 384-393.
9. DeLeon, P. H., & VandenBos, G. R. (2000). Reflecting, and leading: Progress in professional practice in psychology. Professional Psychology: Research and Practice, 31, 595-597.
10. Polen, R. (1994). Letter to the editor. Hawaii Psychologist, 17, 6.
11. Fox, R. E. (1986). Building a profession that is safe for practitioners: A personal perspective. Psychotherapy in Private Practice, 4, 3-12.
12. Fox, R. E. (1996). Charlatanism, scientism, and psychology's social contract. American Psychologist, 51, 777-784.
13. Fox, R. E. (2000). The dark side of evidence-based treatment. Practitioner, 12(2), 5.
14. Fox, R. E., Schwelitz, F. D., & Barclay, A. G. (1992). A proposed curriculum for psychopharmacology training for professional psychologists. Professional Psychology: Research and Practice, 23, 216-219.
15. Hayes, S. C., & Blackledge, J. T. (1998). Creating an alternative to prescription privileges in the era of managed care. In S. C. Hayes & E. M. Heiby (Eds.), Prescription privileges for psychologists: A critical appraisal (pp. 261-278). Reno, NV: Context Press.
16. Hayes, S. C., &, Heiby, E. M. (1996). Psychology's drug problem: Do we need a fax or should we just say no? American Psychologist, 51, 198-206.
17. Hayes, S. C., & Heiby, E. M. (Eds.). (1998). Prescription privileges for psychologists: A critical appraisal. Reno, NV: Context Press.
18. Hoffman, J. C. (1998). Attitudes of directors of training in the San Francisco Bay Area toward the doctor of psychology degree. Dissertation Abstracts International: Section B: The Sciences & Engineering, 58(9-B), 5191.
19. Kirsch, I., & Sapirstein, G. (1999) Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medications. In I. Kirsch (Ed.), How expectancies shape experience (pp. 303-320). Washington, DC: American Psychological Association.
20. Kubie, L. S. (1949). Medical responsibility for training in clinical psychology. Journal of Clinical Psychology, 5, 94-100.
21. Loosbrock, D. L., Tomlin, M. E., Robinson, R. L., Obenchain, R. L., & Croghan, T. W. (2002). Appropriateness of prescribing practices for serotonergic antidepressants. Psychiatric Services, 53, 179-184.
22. Peter, H., Hand, I., & Rufer, M. (2001). Combined treatment of agoraphobia and panic disorders with behavioral and drug therapy. Critical view on meta-analyses. Verhaltenstherapie, 11, 174-178.
23. Piotrowski, C. (1989-1990, Winter). Prescription privileges: A time for some serious thought. Psychotherapy Bulletin, 24, 16-18.
24. Piotrowski, C., & Doelker, R. (2001). Prescription privileges: Attitudes of clinical social workers. Psychological Reports, 88, 606.
25. Riley, W. T., Elliott, R. L., & Thomas, J. R. (1992). Impact of prescription privileging on psychology training: Training director's survey. Clinical Psychologist, 45, 63-70.
26. Salamone, J. D. (2000). A critique of recent studies on placebo effects of antidepressants: Importance of research on active placebos. Psychopharmacology, 152, 1-6.
27. Sammons, M. T. (1998). The case for prescription privileges for psychologists: An overview. In S. C. Hayes & E. M. Heiby (Eds.), Prescription privileges for psychologists: A critical appraisal (pp. 11-46). Reno, NV: Context Press.
28. Sammons, M. T., & Schmidt, N. B. (Eds.). (2001). Combined treatment for mental disorders: A guide to psychological and pharmacological interventions. Washington, DC: American Psychological Association.
29. Scovel, K. A., Christeiisen, O. J., & England, J. T. (2002). Mental health counselors' perceptions regarding psychopharmacological prescriptive rights. Journal of Mental Health Counseling, 24, 36-50.
30. Task Force for Psychosocial Treatment Research in Psychiatry. (1993). Psychosocial treatment research in psychiatry: A task force report of the American Psychiatric Association. Washington, DC: American Psychiatric Association.
31. Telch, M. J., & Lucas, R. A. (1994). Combined pharmacological and psychological treatment of panic disorder: Current status and future directions. In B. E. Wolfe & J. D. Maser (Eds.), Treatment of panic disorder: A consensus development conference (pp. 177-197). Washington, DC: American Psychiatric Press.
32. Templer, D. I., Tomeo, M. E., Pointkowski, S. R., Mitroff, D., Niederhauser, R. N., & Siscoe, K. (2000). Psychology of the scientist: LXXXI. Professional school and traditional program graduates: Comparison on measures of achievement in clinical psychology. Psychological Reports, 86, 951-956.
33. Wallerstein, R. S. (Ed.). (1991). The doctorate in mental health: An experiment in mental health professional education. Lanham, MD: University Press of America.
34. Wazana, A. (2000). Physicians and the pharmaceutical industry. Journal of the American Medical Association, 283, 373-380.